HIPK2 and colorectal cancer: A similar consideration can be made on HIPK2, whose silencing in already transformed cancer cells has been consistently associated to resistance to chemotherapy [46], while its increased expression in stage II colorectal cancers has been shown to predict favorable response to adjuvant chemotherapy [47].